BNET Industries
Baxter International Inc. (BAX) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $11.2B
- Profit
- Dec 31 2007
- $1.7B
- Market Cap
- May 20 2008
- $38.5B
Latest News and Analysis
Baxter International Inc.: Corporate Governance Guidelines
The Board of Directors of Baxter International Inc. recognizes the importance of good corporate governance as a means of addressing the needs of the Company’s stockholders, employees, customers and community. These Guidelines are intended to serve as flexible principles and to be interpreted in the context of all applicable laws...
Additional Resources
Research and Markets: Baxter International Inc. Medical Equipment Company Report Available Now
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c91581) has announced the addition of "Baxter International Inc. Medical Equipment Company Report: Medical Device Company Analysis Covering key Information Relating to Company Market Share by Sector and Country, Financial, SWOT and Value Chain Analysis" to their offering. Baxter International Inc. Medical...
Price of blood thinner has doubled since recall
Major U.S. dialysis centers say the price of blood-thinner heparin has doubled since mid-April because of global recalls and tight supplies since the discovery of contaminated raw product from China. At Renal Advantage's 90 dialysis centers, prices have gone up twice since mid-April, says Angela Newman, vice president....
Professor Sir Michael G. Marmot Selected as 2008 Recipient of the William B. Graham Prize for Health Services Research
ARLINGTON, Va. and DEERFIELD, Ill., May 7 /PRNewswire-FirstCall/ -- In recognition of his lifelong achievements and contributions to the field of health services research, Professor Sir Michael G. Marmot, MBBS, MPH, PhD, FRCP, FFPHM, FMedSci, has been selected as the 2008 recipient of the William B. Graham Prize for...
Baxter's Board of Directors Declares Quarterly Dividend
Shareholders Re-elect Directors and Ratify Auditor at Annual Meeting DEERFIELD, Ill., May 6 /PRNewswire-FirstCall/ -- The Board of Directors of Baxter International Inc. today announced a quarterly dividend and votes taken at the company's Annual Meeting of Shareholders held earlier today. Baxter's Board of...
Families of victims testify in Washington about heparin deaths
WASHINGTON -- The widow of a man who died after receiving contaminated heparin told a congressional subcommittee Tuesday "we have a false sense of security" in a land where people expect to be protected and safe. Brushing away tears, Johanna Marie Staples of Toledo, Ohio, said her...
Heparin plant in China passed 'in-depth' review
The Chinese plant that supplied contaminated heparin to the USA passed an audit by Baxter International just months before Baxter started recalling the blood thinner, according to testimony at a congressional hearing Tuesday. Contaminated heparin has been associated with 81 deaths in the USA and has been found...
Baxter International Inc. Annual Shareholders Meeting
DEERFIELD, Ill., April 30 /PRNewswire-FirstCall/ -- Baxter International , will host its annual shareholders meeting on Tuesday, May 6, 2008, at 11:30 a.m. Eastern Time (10:30 a.m. Central Time). This event is being webcast by Thomson/CCBN and can be accessed along with accompanying slides at Baxter's Web...
Heparin contamination appears deliberate: Baxter CEO
WASHINGTON AFP — US drug-maker Baxter International said Tuesday its blood thinner heparin, which is produced in China and has been linked to dozens of deaths, appears to have been deliberately contaminated. "We're alarmed that one of our products was used in what appears to have been a...
Zacks Bull and Bear of the Day Highlights: China Mobile, Amylin, The Progressive Company, Castle Brands and Baxter International
CHICAGO -- Zacks Equity Research highlights China Mobile (NYSE: CHL) as the Bull of the Day and Amylin Pharmaceuticals (Nasdaq: AMLN) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on The Progressive Company (NYSE: PRG), Castle Brands (NYSE: ROX) and Baxter International (NYSE: BAX). Full...
Effect of toxic heparin spreads
The Food and Drug Administration said Monday that contaminated heparin, a blood thinner, has been detected in 11 countries and that the number of U.S. deaths potentially linked to the contamination has risen to 81, up from 62. The contamination is "a worldwide problem," said Janet Woodcock, director...
Contaminated blood thinner from China is in 11 countries: report
NEW YORK AFP — A contaminated blood thinner from China linked to 81 deaths in the United States is present in drug supplies in 11 countries, the New York Times said Tuesday, citing federal regulators. The US Food and Drug Administration Monday sent a warning letter to Changzhou...
FDA: Contaminated Heparin Found in 11 Countries
Contaminated heparin products have now been found in at least 10 countries, not including the United States, leading to ongoing surveillance measures to ensure the safety of the blood thinner, U.S. health officials announced Monday. or OSCS -- may be responsible for dozens of deaths and hundreds of adverse reactions...
China, U.S. swap charges over heparin
WASHINGTON -- China and the United States traded charges Monday about whether a contaminant in the blood thinner heparin caused severe allergic reactions linked to as many as 81 deaths. Federal health officials said new tests indicated a solid link. China said the contaminant could not be...
Wall Street News Alert: OCOL Is Thursday's Stock to Watch! April 17, 2008
Wall Street News Alert's "stocks to watch" thismorning are: Oncolin Therapeutics (OTCBB: OCOL), Pfizer Incorporated (NYSE: PFE), Gilead Sciences, Inc. (NASDAQ: GILD) and Baxter International Inc.(NYSE: BAX). Having announced this week that a poster representing its lead cancertechnology was being presented at the annual meeting of The AmericanAssociation for Cancer...
Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced
Phase II data from study of GAMMAGARD-treated patients announced at the American Academy of Neurology annual meeting CHICAGO, April 17 /PRNewswire-FirstCall/ -- New York-Presbyterian Hospital/Weill Cornell Medical Center and Baxter International Inc. announced results of a six-month, placebo-controlled Phase II study of 24 patients treated with...
Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
Company Continues to Advance Product Pipeline with Increased Investment in Research & Development DEERFIELD, Ill., April 17 /PRNewswire-FirstCall/ -- Baxter International Inc. today reported solid financial results for the first quarter of 2008, and raised its financial outlook for the full year. For the...
Edwards Lifesciences Announces Retirement of Director Vernon Loucks
IRVINE, Calif., April 16 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , a world leader in the products and technologies to treat advanced cardiovascular disease, announced today that Vernon R. Loucks Jr. is retiring from the company's board of directors, effective May 31, 2008. Loucks, who is chairman of...
Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease
Laboratory study shows naturally occurring antibodies contained in GAMMAGARD LIQUID may bind to the primary culprit for Alzheimer's disease CHICAGO, April 15 /PRNewswire-FirstCall/ -- The University of Tennessee Health Science Center and Baxter International Inc. today announced data from a laboratory study demonstrating natural antibodies contained...
Wall Street News Alert: Breaking News Alert - BPYT! April 15, 2008
Wall Street News Alert's "stocks to watch" thismorning are: Bioponic Phytoceuticals, Inc. (PINKSHEETS: BPYT), Abbott(NYSE: ABT), Baxter International Inc. (NYSE: BAX), Eli Lilly and Company(NYSE: LLY). Bioponic Phytoceuticals, Inc. (PINKSHEETS: BPYT) has issued positive news,and the company should have investors monitoring the stock closely.Yesterday after the markets closed, the company,...
- Next »
- page 1 of 53
- « Previous
Sort byClose
- Incorporated: 1931
- CEO: Mr. Robert L. Parkinson Jr.
Baxter International operates through three primary business segments. Co.'s BioScience business manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as proteins used in hemostasis, wound-sealing and tissue regeneration; and vaccines. Co.'s Medication Delivery business manufactures products used in the delivery of fluids and drugs to patients, and its Renal business provides products to treat end-stage renal disease, or irreversible kidney failure.
Key Competitors
Baxter International Inc. Company Info
Board of Directors
Mr. Robert L. Parkinson Jr.
Chairman
Mr. John D. Forsyth
Ms. Gail D. Fosler
Ms. Carole Uhrich Shapazian
General Walter E. Boomer
Mr. Thomas T. Stallkamp
Lead Director
Dr. Wayne T. Hockmeyer Ph.D.
Dr. Joseph B. Martin M.D., Ph
Mr. Albert P.L. Stroucken
Dr. James R. Gavin III, M.D
Mr. Peter S. Hellman
Mr. Kornelis J. Storm
Mr. Blake E. Devitt
Contact Information
One Baxter Parkway
Deerfield, IL
847 948-2000
